Peixiang Lan

9PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 08, 2026
PARK7-Mediated Delactylation of SF3B Reprograms RNA Splicing to Attenuate Fibrosis and Promote Antitumor Immunity.

|May 20, 2026
PARK7-induced delactylation of ATAD3A impairs mitochondrial fitness to promote exhaustion of tumor-infiltrating CD8+ T cells.

|Apr 27, 2026
CD1d functions as a ligand for PIRA2 to drive macrophage activation in nonalcoholic fatty liver disease.

|Jan 05, 2026
BHLHE40 Orchestrates Effector Tissue-Resident Memory CD8+ T Cells and Limits Long-Term Survival of Kidney Graft.

Junbo Li, Bo Yang, Tianhui Pan

|Jun 24, 2025
Setdb1 ablation in macrophages attenuates fibrosis in heart allografts.

Zhibo Ma, Xi Zhou, Wenlong Jia

|May 15, 2025
Targeting Setdb1 in T cells induces transplant tolerance without compromising antitumor immunity.

Xiaosheng Tan, Xiangli Zhao, Zunsong Hu

Pageof 2

Frequent Collaborators

3 joint publications

Xiaosheng Tan

2 joint publications

Jing Liu

2 joint publications

Gang Chen

2 joint publications

Li Chen